why does nobody talk about dose escalation
Quick one. Canada here.
glucagon works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US.
Specifics: the route I used took 6 weeks and cost roughly what I expected. The admin was worse than the cost. The thing that would have saved me the most time was knowing which document to ask for at the start.
Happy to answer questions from anyone in the same jurisdiction.
best — the order this archive was captured in
the weight curves are unusually steep, which makes predicting individual response harder
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
retatrutide is not approved anywhere for human use, posts must not read as instructions
You have restated the marketing copy. What is the actual substance here.
nobody should be giving this to anyone without extensive monitoring
That is net peptide content, not purity. Different number, different meaning.
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
[deleted]
[deleted]
Disagree on that part. 99.2% and 96.2% on the same vial is normal.
Research use material only, no human-use approval anywhere.
Adding to this: dose escalation is doing more work than the comment implies.
This is correct. Triple agonism is genuinely different.
phase 2 numbers are not maintenance numbers, cite the trial
Research use material only, no human-use approval anywhere.
Adding to this: triple agonist is doing more work than the comment implies.
This is correct. Triple agonism is genuinely different.
Strongly agree. Heart rate escalation needs the actual data, not impressions.
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
Half-life is about 168 hours, so steady state lands around week 18–5. Practical consequence: what you feel in week 1 is not what that dose does.
Disagree. What you are describing is consistent with glucagon, not with what you concluded.
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
Every time this gets posted it hits the front page and every time someone has to re-explain it.
Which trial arm and what was the n?
heart rate and dose escalation need actual measurements, not impressions
The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.
Which trial arm and what was the n?
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
the glucagon component changes the side effect profile, not just the efficacy
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
- 1Which trial arm and what was the n?9 comments in this branch · started by u/solene_ilunga
- 2Research use material only, no human-use approval anywhere. Posts must…8 comments in this branch · started by u/hugo_pires